Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 508536

Pharmaceutically acceptable co-crystalline forms of sildenafil

Žegarac, Miroslav; Meštrović, Ernest; Dumbović, Alojz; Devčić, Maja; Tudja, Petar
Pharmaceutically acceptable co-crystalline forms of sildenafil
(2007)

CROSBI ID: 508536 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Pharmaceutically acceptable co-crystalline forms of sildenafil

Autori
Žegarac, Miroslav ; Meštrović, Ernest ; Dumbović, Alojz ; Devčić, Maja ; Tudja, Petar

Broj patenta
WO 2007/080362

Godina
2007

Datum patenta
19.07.2007.

Sažetak
Co-crystalline forms of sildenafil, process for theor preparation, pharmaceutical compositions contaning the same and therapeutic uses thereof described.

Izvorni jezik
Engleski

Znanstvena područja
Kemija



POVEZANOST RADA

Ustanove:
Pliva-Istraživački institut

Profili:

Avatar Url Ernest Meštrović (autor)

Avatar Url Petar Tudja (autor)

Citiraj ovu publikaciju:

Žegarac, Miroslav; Meštrović, Ernest; Dumbović, Alojz; Devčić, Maja; Tudja, Petar
Pharmaceutically acceptable co-crystalline forms of sildenafil
(2007)
Žegarac, M., Meštrović, E., Dumbović, A., Devčić, M. & Tudja, P. (2007) Pharmaceutically acceptable co-crystalline forms of sildenafil, WO 2007/080362.
@patent{patent, author = {\v{Z}egarac, Miroslav and Me\v{s}trovi\'{c}, Ernest and Dumbovi\'{c}, Alojz and Dev\v{c}i\'{c}, Maja and Tudja, Petar}, year = {2007}, keywords = {}, title = {Pharmaceutically acceptable co-crystalline forms of sildenafil}, keyword = {}, publisherplace = {Zagreb} }
@patent{patent, author = {\v{Z}egarac, Miroslav and Me\v{s}trovi\'{c}, Ernest and Dumbovi\'{c}, Alojz and Dev\v{c}i\'{c}, Maja and Tudja, Petar}, year = {2007}, keywords = {}, title = {Pharmaceutically acceptable co-crystalline forms of sildenafil}, keyword = {}, publisherplace = {Zagreb} }

Podijeli:





Contrast
Increase Font
Decrease Font
Dyslexic Font
CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.